Insmed (INSM) AI Analysis

INSM$122.88+1.72 +1.42%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$26.96BEnterprise value$24.48BRevenue (TTM)$1.52BMarket positionTop 25%

Score

62
Neutral
Value
55
Quality
32
Growth
100

AI Score 35. Insmed Incorporated has a market cap of $24.13 billion but is facing significant challenges with a net profit margin of -39.85% and a price-to-earnings ratio of -39.01. The company is heavily investing in R&D, which is 62.14% of revenue, but continues to report negative net income, indicating ongoing financial struggles despite its innovative pipeline

Insmed (INSM) AI Analysis

INSM price $122.88 +1.72 +1.42%

Ticker
INSM
Price
$122.88
Change
+1.72 +1.42%
Market cap
$26.96B
Forward P/E
116.07
Dividend yield
0.00%
Beta
0.81
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
55
Quality
32
Growth
100

Stocklytics score rationale: value 55, quality 32, growth 100.

AI Score 35. Insmed Incorporated has a market cap of $24.13 billion but is facing significant challenges with a net profit margin of -39.85% and a price-to-earnings ratio of -39.01. The company is heavily investing in R&D, which is 62.14% of revenue, but continues to report negative net income, indicating ongoing financial struggles despite its innovative pipeline

Insights · Forecast · Financials · Learn

Stocklytics home · Screener